Causes, Trends, and Predictors of 90-Day Readmissions After Spontaneous Coronary Artery Dissection (from A Nationwide Readmission Database) by Virk, Hafeez Ul Hassan, Tripathi, Byomesh, Kumar, Varun, Lakhter, Vladimir, Khan, Muhammed Shahzeb, Ijaz, Sardar Hassan, Dean, Saima, Gupta, Shuchita, Sharma, Purnima, Mishra, Rohi, George, Jon C., Gopalan, Radha, Zidar, David, Janzer, Sean

Get full text

ETIOLOGIES AND TRENDS OF 90-DAY READMISSIONS AFTER SPONTANEOUS CORONARY ARTERY DISSECTION (SCAD): A NATIONAL POPULATION-BASED COHORT STUDY by Tripathi, Byomesh, Hassan, Fnu Hafeez, Viray, Michael, Castellanos, Jasmin Martinez, De Guevara, Emiliana Franco Ladron, Dean, Saima, Shah, Harshil, Kalra, Sanjog, Bonita, Raphael, Amanullah, Aman, George, Jon, Pressman, Gregg, Figueredo, Vincent

Get full text

Secondary Myelodysplastic Syndrome/Acute Myeloblastic Leukemia During Lenalidomide-Based Regimens in Relapsed and/or Refractory Multiple Myeloma Patients: Single Center Experience by Kotchetkov, Rouslan, Masih-Khan, Esther, Chu, Chia-Min, Trieu, Young, Dean, Saima, Maganti, Manjula, Chen, Christine I., Kukreti, Vishal, Trudel, Suzanne, Reece, Donna E.

Get full text

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma by Reece, Donna E., Masih-Khan, Esther, Khan, Arooj, Dean, Saima, Fung, Sharon, Anglin, Peter, Chen, Christine, Kukreti, Vishal, Mikhael, Joseph R., Trudel, Suzanne

Get full text

Incidence and Characteristics of Secondary Myelodysplastic Syndrome Developing During Lenalidomide-Based Regimens In Relapsed and/or Refractory Multiple Myeloma Patients by Reece, Donna E., Masih-Khan, Esther, Goswami, Rashmi S., Fung, Sharon, Barth, David, Chen, Christine, Kukreti, Vishal, Sun, Haowei (Linda), Dean, Saima, Trudel, Suzanne

Get full text

Infectious Complications in Advanced Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide (Revlimid +/- Corticosteroids) by Kukreti, Vishal, Masih-Khan, Esther, Dean, Saima, Kumar, Deepali, Mikhael, Joseph R., Trudel, Suzanne, Reece, Donna E., Chen, Christine

Get full text

Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma by Reece, Donna E., Masih-Khan, Esther, Khan, Arooj, Dean, Saima, Anglin, Peter, Chen, Christine, Kukreti, Vishal, Mikhael, Joseph R., Trudel, Suzanne

Get full text

Use of Lenalidomide (Revlimid® +/− Corticosteroids in Relapsed/Refractory Multiple Myeloma Patients with Elevated Baseline Serum Creatinine Levels by Reece, Donna E., Masih-Khan, Esther, Chen, Christine, Wang, Lisa, Dean, Saima, Kukreti, Vishal, Mikhael, Joseph R., Trudel, Suzanne, Knight, Robert, Zeldis, Jerome

Get full text

Lenalidomide (Revlimid®) +/− Corticosteroids in Elderly Patients with Relapsed/Refractory Multiple Myeloma by Reece, Donna E., Masih-Khan, Esther, Chen, Christine, Wang, Lisa, Dean, Saima, Trudel, Suzanne, Mikhael, Joseph R., Kukreti, Vishal, Knight, Robert, Zeldis, Jerome

Get full text

Learning Active Implementation Frameworks: the role of implementation teams in a case study from Pakistan by Hamid, Saima, Mureed, Sheh, Kayani, Aasia, Javed, Kiran, Khan, Adnan, Awais, Sayema, Khan, Neelam, Tus-Salam, Fakiha, Fixsen, Dean L.

Get full text

Rationale and design of the CONFIRM2 (Quantitative COroNary CT Angiography Evaluation For Evaluation of Clinical Outcomes: An InteRnational, Multicenter Registry) study by van Rosendael, Alexander R., Crabtree, Tami, Bax, Jeroen J., Nakanishi, Rine, Mushtaq, Saima, Pontone, Gianluca, Andreini, Daniele, Buechel, Ronny R., Gräni, Christoph, Feuchtner, Gudrun, Patel, Toral R., Choi, Andrew D., Al-Mallah, Mouaz, Nabi, Faisal, Karlsberg, Ronald P., Rochitte, Carlos E., Alasnag, Mirvat, Hamdan, Ashraf, Cademartiri, Filippo, Marques, Hugo, Kalra, Dinesh, German, David M., Gupta, Himanshu, Hadamitzky, Martin, Deaño, Roderick C., Khalique, Omar, Knaapen, Paul, Hoffmann, Udo, Earls, James, Min, James K., Danad, Ibrahim

Get full text

Inhibition of Inducible Nitric Oxide Synthase by Peroxisome Proliferator-Activated Receptor Agonists: Correlation with Induction of Heme Oxygenase 1 by Colville-Nash, Paul R, Qureshi, Saima S, Willis, Dean, Willoughby, Derek A

Get full text